Press Releases
Ceapro Inc. Announces Completion of Patient Enrollment in Clinical Study Evaluating Beta Glucan as a Cholesterol-Lowering Agent
Ceapro Inc. Reports 2021 First Quarter Financial Results and Highlights
Ceapro Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
Ceapro Inc. Announces Successful Completion of Collaborative Research and Development Program with University of Alberta
Ceapro Inc. to Present at the H.C. Wainwright Global Life Sciences Conference
Ceapro Inc. to Present at NobleCon17
Ceapro Inc. to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference
Ceapro Inc. Reports 2020 Third Quarter and Nine-Month Financial Results and Operational Highlights
Ceapro Inc. Announces Additional Funding for Innovative PGX Technology Project
